Characteristics of patients with Budd-Chiari syndrome (BCS) and portal vein thrombosis (PVT) and controls
| . | BCS n = 43 . | PVT n = 92 . | Controls n = 474 . |
|---|---|---|---|
| Age* (y) | 40 (19-60) | 51 (19-83) | 47 (16-73) |
| Male (%) | 16 (37) | 48 (52) | 202 (43) |
| Oral anticoagulation (%) | 32 (74) | 24 (26) | — |
| Duration of disease* (y) | 6.4 (0.3-25) | 7.0 (0.5-45) | — |
| Myeloproliferative disorders (%) | 12 (28) | 16 (17) | — |
| Polycythemia vera (%) | 10 (23) | 8 (9) | — |
| Essential thrombocythemia (%) | 1 (2) | 3 (3) | — |
| Myelofibrosis (%) | — | 4 (4) | — |
| Unclassified (%) | 1 (2) | 1 (1) | — |
| PNH (%) | — | 2 (2) | — |
| Lupus anticoagulant (%) | 2 (5) | — | — |
| Biopsy documented cirrhosis (%) | 6 (14) | 16 (17) | — |
| History of pancreatitis (%) | — | 10 (11) | — |
| Previous abdominal surgery (%) | 10 (23) | 28 (30) | NA |
| Oral contraceptives (%) | 12 (28) | 12 (13) | 65 (14) |
| . | BCS n = 43 . | PVT n = 92 . | Controls n = 474 . |
|---|---|---|---|
| Age* (y) | 40 (19-60) | 51 (19-83) | 47 (16-73) |
| Male (%) | 16 (37) | 48 (52) | 202 (43) |
| Oral anticoagulation (%) | 32 (74) | 24 (26) | — |
| Duration of disease* (y) | 6.4 (0.3-25) | 7.0 (0.5-45) | — |
| Myeloproliferative disorders (%) | 12 (28) | 16 (17) | — |
| Polycythemia vera (%) | 10 (23) | 8 (9) | — |
| Essential thrombocythemia (%) | 1 (2) | 3 (3) | — |
| Myelofibrosis (%) | — | 4 (4) | — |
| Unclassified (%) | 1 (2) | 1 (1) | — |
| PNH (%) | — | 2 (2) | — |
| Lupus anticoagulant (%) | 2 (5) | — | — |
| Biopsy documented cirrhosis (%) | 6 (14) | 16 (17) | — |
| History of pancreatitis (%) | — | 10 (11) | — |
| Previous abdominal surgery (%) | 10 (23) | 28 (30) | NA |
| Oral contraceptives (%) | 12 (28) | 12 (13) | 65 (14) |
PNH indicates paroxysmal nocturnal hemoglobinuria; NA, not available.
Median (range).